Keyphrases
Chronic Kidney Disease
91%
Glucagon-like
89%
End-stage Renal Disease
76%
Estimated Glomerular Filtration Rate
72%
Dialysis
68%
Type 2 Diabetes Mellitus (T2DM)
62%
Kidney Transplantation
61%
Hemodialysis
57%
Type 2 Diabetic Patients
57%
Continuous Glucose Monitoring
51%
Glomerular Filtration Rate
50%
Post-transplant Diabetes Mellitus
50%
Renal Function
49%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
42%
Egfr
42%
Uremic Patients
41%
Transplantation
41%
Diabetes
38%
Lung Transplantation
36%
Glucagon
36%
Solid Organ Transplantation
35%
Kidney Function
34%
Confidence Interval
33%
Kidney Disease
32%
Kidney
32%
Non-diabetic
31%
Pre-diabetes (pre-DM)
31%
Without Diabetes
30%
Hemoglobin A1c (HbA1c)
29%
Risk Factors
29%
Liraglutide
29%
Cardiac Surgery
29%
Type 1 Diabetes Mellitus (T1DM)
27%
Maintenance Hemodialysis Patients
27%
Denmark
26%
Mesenteric Blood Flow
24%
Rapid Decline
24%
Randomized Controlled Trial
23%
First Week
23%
A1 Receptor
22%
Non-alcoholic Fatty Liver Disease (NAFLD)
22%
Dapagliflozin
22%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
22%
Older Patients
22%
Endotrophin
22%
Patients with Diabetes
21%
Randomized Placebo-controlled Trial
21%
Creatinine
20%
Incretin Hormones
20%
Pretransplant
19%
Medicine and Dentistry
Glomerular Filtration Rate
100%
Kidney Function
95%
Chronic Kidney Disease
89%
Diabetes Mellitus
88%
Diabetes
75%
End Stage Renal Disease
68%
Kidney Transplantation
56%
Nephropathy
54%
Hemodialysis
46%
Drug Therapy
42%
Transplantation
42%
Sodium Glucose Cotransporter 2 Inhibitor
41%
Glucagon Like Peptide 1
41%
Lung Transplantation
36%
Impaired Glucose Tolerance
35%
Patient with Type 2 Diabetes
34%
Disease
32%
Creatinine
31%
Cardiovascular System
29%
Placebo
28%
Maturity Onset Diabetes of the Young
28%
Kidney Graft
25%
Hemoglobin A1c
25%
Heart Surgery
25%
Edetic Acid
25%
Glucagon Like Peptide 2
23%
Cardiovascular Disease
22%
Dapagliflozin
22%
Frailty
22%
Urokinase Receptor
22%
Randomized Controlled Trial
22%
Mesentery Blood Flow
22%
Incretin
22%
Acute Kidney Injury
21%
Glucagon
20%
Emergency Department
19%
Solid Organ Transplantation
19%
Biological Marker
19%
Patient with Diabetes
19%
Prevalence
18%
Gastric Inhibitory Polypeptide
17%
Glucagon-Like Peptide-1 Agonist
17%
Chromium 51
16%
Peritoneal Dialysis
15%
Diabetic Nephropathy
15%
Glycemic Control
15%
Mannose Binding Lectin
14%
Nonalcoholic Fatty Liver
14%
Chronic Pancreatitis
14%
Jejunostomy
14%
